Trypanosoma brucei

7,668 views

Published on

Trypanosoma brucei

1 Comment
15 Likes
Statistics
Notes
No Downloads
Views
Total views
7,668
On SlideShare
0
From Embeds
0
Number of Embeds
12
Actions
Shares
0
Downloads
539
Comments
1
Likes
15
Embeds 0
No embeds

No notes for slide

Trypanosoma brucei

  1. 1. TRYPANOSOMA BRUCEI Dr.T.V.Rao MDDR.T.V.RAO MD 1
  2. 2. TAXONOMY• Phylum Mastigophora• Sub-Phylum Sarcomastigophora• Class Zoomastigophora• Order Kinetoplastidae• Genus Trypanosoma ? species of mammals, birds, reptiles and amphibians
  3. 3. TRYPANOSOMA BRUCEI• Parasitic eukaryotes that diverged 200-500 million years ago.• Pathogens of the African Sleeping Sickness.• Transfer from the gut of the Tsetse fly to the From Mark Field’s lab bloodstream of humans and cattle. website• Unique biology: S.C . - Kinetoplast - Antigenic variation - trans-splicing IAEA DR.T.V.RAO MD 3
  4. 4. TRYPANOSOMIASIS • Trypanosomes were first described in frogs 1855 • Griffith Evans identifies T. evansi as agent of surra (a horse and camel disease) in 1880 • David Bruce identifies T. brucei as cause of Nagana and demonstrates transmission by Tse-tse flies David Bruce, 1855-1931DR.T.V.RAO MD 4
  5. 5. SLEEPING SICKNESS – AS PER WHO• African Trypanosomiasis, also known as "sleeping sickness," is caused by microscopic parasites of the species Trypanosoma brucei. It is transmitted by the tsetse fly (Glossina species), which is found only in rural Africa. historically, it has been a serious public health problem in some regions of sub-Saharan Africa. Currently, about 10,000 new cases each year are reported to the World Health organization; however, it is believed that many cases go undiagnosed and unreported.DR.T.V.RAO MD 5
  6. 6. TRYPANOSOMA BRUCEI• Trypanosoma brucei is a protozoan with flagella (protist) species that causes African trypanosomiasis (or sleeping sickness) in humans and nagana in animals in Africa. There are 3 sub-species of T. brucei: T. b. brucei, T. b. gambiense and T. b. rhodesiense.DR.T.V.RAO MD 6
  7. 7. AFRICAN SLEEPING SICKNESS• Parasite - Trypanosoma brucei ssp • Trypanosoma brucei rhodesiense • Trypanosoma brucei gambiense• Vector - Tse Tse fly • Glossina mortisans (Eastern Africa) • Glossina palpalis (Western Africa) DR.T.V.RAO MD 7
  8. 8. AN OBLIGATE AND COMPLEX PARASITE• These obligate parasites have two hosts - an insect vector and mammalian host. Due to the large difference between these hosts the trypanosome undergoes complex changes during its life cycle to facilitate its survival in the insect gut and the mammalian bloodstream. It also features a unique and notable variable surface glycoprotein (VSG) coat in order to avoid the hosts immune system. There is an urgent need for the development of new drug therapies as current treatments can prove fatal to the patient as well as the trypanosomes.DR.T.V.RAO MD 8
  9. 9. AFRICAN TRYPANOSOMIASISSleeping Sickness, vector is the tsetse flyClassical example of an emerging infection, 1890-1930Leading public health problem in Africa during that time,colonialism brought it to new areasNearly eliminated by 1960 using population screening,case treatment, chemoprophylaxisRe-emerging infection in central Africa
  10. 10. SLEEPING SICKNESS - BACKGROUND• Human African Trypanosomiasis (HAT) occurs in 36 sub-Saharan Africa countries• Dependent upon Tsetse fly (Glossina spp) vectors.• Highest exposure in rural populations dependent on agriculture, fishing, animal husbandry or hunting. Cattle is the key mode of human-animal transmission.• Occurs in two forms, a chronic form, that accounts for 95% of reported cases of sleeping sickness, and an acute form. Each form has different vectors with different modes of transmission.• After continued control efforts, the number of cases reported in 2009 has dropped below 10 000 for first time in 50 years. This trend has been maintained in 2010 with 7139 new cases reported.DR.T.V.RAO MD 10
  11. 11. TRYPANOSOMIASIS• The insect vector for T. brucei is the tsetse fly. The parasite lives in the midgut of the fly (procyclic form), whereupon it migrates to the salivary glands for injection to the mammalian host on biting. The parasite lives within the bloodstream (bloodstream form) where it can reinfect the fly vector after biting. Later during a T. brucei infection the parasite may migrate to other areas of the host. A T. brucei infection may be transferred human to human via bodily fluid exchange, primarily blood transfusion..DR.T.V.RAO MD 11
  12. 12. DISTRIBUTIONDR.T.V.RAO MD 12
  13. 13. EPIDEMIOLOGY OF SLEEPING SICKNESS• .T.b. gambiense is predominant in the western and central regions of Africa, whereas T. b. rhodesiense is restricted to the eastern third of the continent . 6,000 to 10,000 human cases are documented annually. 35 million people and 25 million cattle are at risk. Regional epidemics of the disease are cause of major health and economic disasters.DR.T.V.RAO MD 13
  14. 14. THREE DIFFERENT SUB-SPECIES OF T. BRUCEI,• T. brucei gambiense - Causes slow onset chronic trypanosomiasis in humans. Most common in central and western Africa, where humans are thought to be the primary reservoir.• T. brucei rhodesiense - Causes fast onset acute trypanosomiasis in humans. Most common in southern and eastern Africa, where game animals and livestock are thought to be the primary reservoir.• T. brucei brucei - Causes animal African trypanosomiasis, along with several other species of trypanosoma. T. b. brucei is not human infective due to its susceptibility to lysis by human apolipoprotein L1. However, as it shares many features with T. b. gambiense and T. b. rhodesiense (such as antigenic variation) it is used as a model for human infections in laboratory and animal studies.DR.T.V.RAO MD 15
  15. 15. AFRICAN SLEEPING SICKNESS T .b.gambiense T.b.rhodesiense• Virulence Less More• Reservoir Human/animal Human/animal• Zoonotic Less More• Vector G.palpalis G.mortisans• Distribution Western Africa Eastern Africa
  16. 16. ANTIGENIC VARIATION • 6-10% of the total genome of African trypanosomes is coding for VSGs (more than 1000 genes) • Only one is expressed at a given time the other 999 genes are shut down and completely silent (allelic exclusion) • At a low frequency a switch to a different gene occurs, if the host develops antibodies against the previous VSG the new clone is strongly selected • What is the advantage of expressing a single VSG? • How is expression controlled? • What mechanisms can you think of by which a cell could control gene expression and protein abundance?DR.T.V.RAO MD 17
  17. 17. ANTIGENIC VARIATION• mRNA derived from only a single VSG gene can be detected at one time• VSG expression is controlled at the level of transcription initiation• Regulation of promoter activity is used to control gene expression in many organismsDR.T.V.RAO MD 18
  18. 18. ANTIGENIC VARIATION• If it is not the promoter or the processing maybe it is the exact location in the genome that predisposes a specific VSG for expression• Where are active and inactive genes in the genome?• How could a location based system switch?DR.T.V.RAO MD 19
  19. 19. ANTIGENIC VARIATION • All VSGs are 65 kDA glycoproteins, and are present on the surface as dimers • The outer domain is highly variable and the only conservation detected is the position of cysteines • Other (non-variant) proteins like transferrin receptor or hexose transporter are hidden in the this surface coat
  20. 20. AFRICAN TRYPANOSOMIASIS THE LIFE CYCLE Human Tse fly Trypomastigote Trypomastigote Stumpy Metacyclic Intermediate Epimastigote Slender Trypomastigote
  21. 21. DR.T.V.RAO MD 22
  22. 22. TSE TSE FLIES ARE VECTORS • Parasites are taken up with the blood meal (stumpy forms are cell cycle arrested and ‘ready to go’ for the next host • Transformation into procyclic trypomastigotes in the midgut • Migration into the ectoperitrophic space where parasites replicate • Passage into salivary glands, differentiation into epimastigotes which attach to the epithelium and massively replicate • Transformation into infectious metacyclic trypomastigotes • Again these are cell cycle arrested ‘sleepers’DR.T.V.RAO MD 23
  23. 23. TRYPANOSOMA BRUCEI LIFE CYCLE • For our purposes we will consider only two life cycle stages trypomastigotes in vertebrate host and epimastigote in Glossina which will be transmitted anterior station or salivarian transmission to the vertebrate host.DR.T.V.RAO MD 24
  24. 24. LIFE CYCLE OF T. BRUCEIDR.T.V.RAO MD 25
  25. 25. CYCLE OF EVENTS• 1.Uninfected tsetse fly (Glossina) bites an infected vertebrate host and ingests trypomastigote circulating in the bloodstream.• 2. Trypomastigotes multiply by longitudinal binary fission in fly gut.•DR.T.V.RAO MD 26
  26. 26. CYCLE OF EVENTS • 3 Trypomastigotes migrate to the salivary glands and transform into epimastigotes and multiply for several generation. •DR.T.V.RAO MD 27
  27. 27. CYCLE OF EVENTS• 4 Epimastigotes transform back into Metacyclic Trypomastigotes (short stumpy forms) in the salivary glands. These form the infective stage.DR.T.V.RAO MD 28
  28. 28. CYCLE OF EVENTS • 5 Tsetse fly bites a human or ruminant host and inoculates metacyclic trypomastigotes into bloodstream.DR.T.V.RAO MD 29
  29. 29. CYCLE OF EVENTS• 6 Trypomastigotes live and multiply in the blood and lymph. In some cases, trypomastigotes migrate to the central nervous system.DR.T.V.RAO MD 30
  30. 30. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION• There are four phases.• The first two phases of Trypanosomiasis only show up in people of non- African decent (Europeans).DR.T.V.RAO MD 31
  31. 31. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION• Phase II: Trypomastigotes enter circulation. • Fever • Headache • Skin rash • Duration is variableDR.T.V.RAO MD 32
  32. 32. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION • Phase III: Trypomastigotes collect in lymph nodes and channels. • Cells not invaded but there is proliferation of endothelial cells • Infiltration of leukocytes • Enlargement of lymph nodesDR.T.V.RAO MD 33
  33. 33. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION• Phase III: Trypomastigotes collect in lymph nodes and channels. • Fever, headache, and delayed sensation to pain • General weakness • Duration many years with T. b. gambiense; less than 1 year and usually less than 4 mo for T. b. rhodesienseDR.T.V.RAO MD 34
  34. 34. PHASE III Enlargement of lymph nodes in cervical triangle (on back of neck) Winterbottom’s Sign one of the cardinal signs of African Trypanosomiasis.DR.T.V.RAO MD 35
  35. 35. PARASITEMIADR.T.V.RAO MD 36
  36. 36. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION • Phase IV: Invasion of Central Nervous System- African Sleeping Sickness.DR.T.V.RAO MD 37
  37. 37. AFRICAN TRYPANOSOMIASIS COURSE OF INFECTION • Phase IV: Invasion of Central Nervous System-African Sleeping Sickness. • Headaches are severe • Emaciation • Mental dullness • Apathy; disinclination to work • Drowsiness and coma • Death from asthenia, heart failure, meningitis, severe fall, etc.DR.T.V.RAO MD 38
  38. 38. DIAGNOSIS OF AFRICAN TRYPANOSOMIASIS• The diagnosis of African Trypanosomiasis is made through laboratory methods, because the clinical features of infection are not sufficiently specific. The diagnosis rests on finding the parasite in body fluid or tissue by microscopy. The parasite load in T. b. rhodesiense infection is substantially higher than the level in T. b. gambiense infectionDR.T.V.RAO MD 39
  39. 39. DIAGNOSING T. B. GAMBIENSE INFECTION• The classic method for diagnosing T. b. gambiense infection is by microscopic examination of lymph node aspirate, usually from a posterior cervical node. It is often difficult to detect T. b. gambiense in blood. Concentration techniques and serial examinations are frequently needed. Serologic testing is available outside the U.S. for T. b. gambiense; however, it normally is used for screening purposes only and the definitive diagnosis rests on microscopic observation of the parasite.DR.T.V.RAO MD 40
  40. 40. IMPORTANCE OF CSF EXAMINATION• All patients diagnosed with African trypanosomiasis must have their cerebrospinal fluid examined to determine whether there is involvement of the central nervous system, since the choice of treatment drug(s) will depend on the disease stage. The World Health Organization criteria for central nervous system involvement include increased protein in cerebrospinal fluid and a white cell count of more than 5. Trypanosomes can often be observed in cerebrospinal fluid in persons with second stage infection.DR.T.V.RAO MD 41
  41. 41. RAPID TESTING METHODS IN AFRICA• Detecting trypanosomes in T. b. gambiense infection is more difficult. The card agglutination test for trypanosomiasis/T. b. gambiense is a serologic screening test used for mass population screening in endemic areas of Africa.DR.T.V.RAO MD 42
  42. 42. WHY IS TRYPANOSOMIASIS SO DEADLY? • Trypanosomes are highly susceptible to antibodies and complement • They live fully exposed to antibodies in the blood stream • They induce a very strong antibody response • Still they manage to thrive in the same host for a year or longer, until the host diesDR.T.V.RAO MD 43
  43. 43. WHY IS TRYPANOSOMIASIS SO DEADLY? • Infection is characterized by periodic waves of Parasitemia • Each wave represents a single antigenically distinct clone or serotype • Antibodies produced in the first week against clone A will not react with clone B • The changing display of different antigens is called antigenic variation • Antigenic variation is an important form of immune evasionDR.T.V.RAO MD 44
  44. 44. MANAGEMENT OF TRYPANOSOMIASIS • Disease management in three steps:• 1) Screening for potential infection. Serological tests and/or checking for swollen cervical glands.• 2) Diagnosis shows whether the parasite is present.• 3) Staging to determine the disease progression. -examination of cerebro-spinal fluid by lumbar puncture
  45. 45. CHEMOTHERAPY• Early stage - most recover • Suramin • Melasporol • Pentamidine• Late stage - upto 5% relapse • Only Melasporol • 10% encephalitisDR.T.V.RAO MD 46 - 5% fatal
  46. 46. TREATMENTS FOR TRYPANOSOMIASISFirst stage treatments:Pentamidine: discovered in 1941, used against T.b.gambiense. Despite a few undesirable effects, it is welltolerated by patients. Only drug easily available in the US.Suramin: discovered in 1921, used against T.b. rhodesiense.Effects in the urinary tract and allergic reactions.Second stage treatments:Melarsoprol: discovered in 1949, used against both forms.Arsenic derivative with many side effects. Fatalencephalopathy (3% to 10%). 1997 resistance up to 30%.Eflornithine: was registered in 1990. Only effective againstT.b. gambiense. Less toxic alternative to melarsoprol, but theregimen is strict and difficult to apply.
  47. 47. PREVENTION CONTINUES TO BE DIFFICULT• The most effective means of prevention is to avoid contact with tsetse flies. Vector eradication is impractical due to the vast area involved. Immunization has not been effective due to antigenic variation.DR.T.V.RAO MD 48
  48. 48. • Programme Created by Dr.T.V.Rao MD for Medical and Health Care Workers • Email • doctortvrao@gmail.comDR.T.V.RAO MD 49

×